TLPH — TALPHERA, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1427925 ·
Last close
$1.19
Market Cap
$61.77M
52W High
$1.50
52W Low
$0.76
ADV30
288,586
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -3,948,000 | -2,556,000 | 30,155,000 | 3,823,000 | 11,677,000 |
| Dec 2025 | 0 | — | -3,453,000 | -3,772,000 | 29,719,000 | 5,894,000 | 12,684,000 |
| Sep 2025 | 1,000 | — | -3,422,000 | -4,436,000 | 30,742,000 | 3,457,000 | 11,565,000 |
| Jun 2025 | 0 | — | -3,693,000 | -3,489,000 | 16,515,000 | 6,791,000 | 9,888,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,294,000
Investing CF
$-17,059,000
Financing CF
$26,788,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.31
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-474,076,000
Inventory
—
Receivables
—
ST Investments
$17,285,000
EBIT TTM
$-15,645,000
Pretax Income TTM
$-14,253,000
Interest Exp TTM
$0
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,000
EBITDA
—
Free Cash Flow
$-6,870,875
Enterprise Value
$51,190,896
Total Cash
$17,076,000
Total Debt
$6,499,000
Shares Out
51,905,796
Trailing EPS
$-0.23
Book Value
$0.37
ROE
-143.4%
ROA
-42.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 28,000 | -13,484,000 | -14,290,000 | 29,719,000 | 12,684,000 | — | -11,364,000 |
| Dec 2024 | 0 | -15,252,000 | -13,004,000 | 18,236,000 | 10,235,000 | — | -12,683,000 |
| Dec 2023 | 651,000 | -16,889,000 | -18,397,000 | 20,395,000 | 6,290,000 | — | -17,492,000 |
| Dec 2022 | 0 | -20,352,000 | 47,755,000 | 47,487,000 | 25,673,000 | — | -28,331,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.24
Max Pain — expiry 2026-12-18
max pain strike: $1.00 · spot: $1.20 · call oi: 3,251 · put oi: 1,952
Expected Move to 2026-12-18:
±$0.55
(45.70%) —
implied range
$0.65 –
$1.75
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | $61.28M | $0.32 | — |
| XLO | Xilio Therapeutics, Inc. | $60.47M | $9.19 | — |
| PRRUF | IMMUTEP Ltd | $58.95M | $0.04 | — |
| HYFT | MindWalk Holdings Corp. | $64.84M | $1.38 | — |
| INCR | Intercure Ltd. | $64.91M | $5.48 | — |
News headlines (Yahoo Finance, 1h cache)
Talphera (TLPH) Q2 2026 Earnings Call Transcript
2026-08-19 21:28 · Yahoo
Talphera Inc (TLPH) (Q2 2026) Earnings Call Highlights: NEPHRO Study Enrollment Hits 75% as ...
2026-08-13 05:03 · Yahoo
Talphera Q2 Earnings Call Highlights
2026-08-13 03:04 · Yahoo
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEFRO Study Progress Amid Rising ...
2026-05-14 05:02 · Yahoo
Talphera Q1 2026 Earnings Call Transcript
2026-05-13 21:40 · Yahoo
Talphera (TLPH) Q1 2026 Earnings Transcript
2026-05-13 21:37 · Yahoo
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-13 20:05 · Yahoo
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026
2026-05-07 20:05 · Yahoo
Talphera, Inc. Q2 2026 Earnings Call Summary
2026-08-14 01:30 · Yahoo
Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update
2026-08-12 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.